These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22946868)

  • 1. Plasma pharmacokinetics of antimicrobial agents in critically ill patients.
    Pea F
    Curr Clin Pharmacol; 2013 Feb; 8(1):5-12. PubMed ID: 22946868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
    Varghese JM; Roberts JA; Lipman J
    Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
    Blot S; Lipman J; Roberts DM; Roberts JA
    Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
    Blot SI; Pea F; Lipman J
    Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.
    Phe K; Heil EL; Tam VH
    J Infect Dis; 2020 Jul; 222(Suppl 2):S132-S141. PubMed ID: 32691832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.
    Alobaid AS; Hites M; Lipman J; Taccone FS; Roberts JA
    Int J Antimicrob Agents; 2016 Apr; 47(4):259-68. PubMed ID: 26988339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency department antimicrobial considerations in severe sepsis.
    Green RS; Gorman SK
    Emerg Med Clin North Am; 2014 Nov; 32(4):835-49. PubMed ID: 25441038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of antimicrobial drugs in intensive care unit patients.
    Macedo RS; Onita JH; Wille MP; Furtado GH
    Shock; 2013 May; 39 Suppl 1():24-8. PubMed ID: 23481498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preface: optimizing antimicrobial therapy of sepsis and septic shock.
    Kumar A
    Crit Care Clin; 2011 Jan; 27(1):xi-xii. PubMed ID: 21144982
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing antimicrobial therapy in sepsis and septic shock.
    Kumar A
    Crit Care Clin; 2009 Oct; 25(4):733-51, viii. PubMed ID: 19892250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some current issues in the pharmacokinetics/pharmacodynamics of antimicrobials in intensive care.
    Petrosillo N; Drapeau CM; Agrafiotis M; Falagas ME
    Minerva Anestesiol; 2010 Jul; 76(7):509-24. PubMed ID: 20613692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer.
    Theuretzbacher U
    Clin Infect Dis; 2012 Jun; 54(12):1785-92. PubMed ID: 22437238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefuroxime Bayesian pharmacokinetics in severely ill septic children].
    Lares-Asseff I; Lugo-Goytía G; Pérez-Guillé MG; Flores-Pérez J; Juárez-Olguín H; Raquel Moreno MA
    Rev Invest Clin; 1998; 50(4):311-6. PubMed ID: 9830319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.
    Roberts JA; Joynt GM; Choi GY; Gomersall CD; Lipman J
    Int J Antimicrob Agents; 2012 Mar; 39(3):187-92. PubMed ID: 22226651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients.
    Winterboer TM; Lecci KA; Olsen KM
    J Pharm Pract; 2010 Feb; 23(1):6-18. PubMed ID: 21507788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of anti-infective agents in critically ill patients.
    Jager NG; van Hest RM; Lipman J; Taccone FS; Roberts JA
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):961-79. PubMed ID: 27018631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.